Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $10.7 million.

  • PROCEPT BioRobotics' Current Deferred Revenue rose 3349.61% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 3349.61%. This contributed to the annual value of $9.6 million for FY2024, which is 6911.24% up from last year.
  • Latest data reveals that PROCEPT BioRobotics reported Current Deferred Revenue of $10.7 million as of Q3 2025, which was up 3349.61% from $9.9 million recorded in Q2 2025.
  • PROCEPT BioRobotics' Current Deferred Revenue's 5-year high stood at $10.7 million during Q3 2025, with a 5-year trough of $848000.0 in Q3 2021.
  • In the last 5 years, PROCEPT BioRobotics' Current Deferred Revenue had a median value of $5.0 million in 2023 and averaged $5.3 million.
  • As far as peak fluctuations go, PROCEPT BioRobotics' Current Deferred Revenue soared by 33991.42% in 2021, and later soared by 3349.61% in 2025.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Current Deferred Revenue stood at $1.0 million in 2021, then skyrocketed by 178.54% to $2.9 million in 2022, then skyrocketed by 98.11% to $5.7 million in 2023, then soared by 69.11% to $9.6 million in 2024, then grew by 11.5% to $10.7 million in 2025.
  • Its Current Deferred Revenue was $10.7 million in Q3 2025, compared to $9.9 million in Q2 2025 and $9.8 million in Q1 2025.